Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.
about
Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future : Views from a workshop at the European Medicines Agency (EMA)Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulationMeasurement of non-VKA oral anticoagulants versus classic ones: the appropriate use of hemostasis assays.Rivaroxaban and apixaban in orthopaedics: is there a difference in their plasma concentrations and anticoagulant effects?The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulantsMonitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillationReversal of anticoagulant effects in patients with intracerebral hemorrhage.The challenges and limitations of widespread direct oral anticoagulant treatment: practical suggestions for their best use.Current challenges and future prospects in oral anticoagulant therapy.The laboratory's 2015 perspective on direct oral anticoagulant testing.The place of viscoelastic testing in clinical practice.The discovery of dabigatran etexilate for the treatment of venous thrombosis.Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme.Perimesencephalic nonaneurysmal subarachnoid hemorrhage caused by transverse sinus thrombosis: A case report and review of literature.Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in.Effects of rivaroxaban on routine coagulation screening tests using commonly used reagents.Poor comparability of coagulation screening test with specific measurement in patients receiving direct oral anticoagulants: results from a multicenter/multiplatform study.Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.To measure or not to measure direct oral anticoagulants before surgery or invasive procedures.A performance evaluation of a novel human recombinant tissue factor prothrombin time reagent (Revohem™ PT).Prothrombin times in the presence of edoxaban - in-vivo experience from King's College hospital.Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register.Peri-operative management of anticoagulation and antiplatelet therapy.Dilemmas in the use of new oral anticoagulants.Assembly and evaluation of an inventory of guidelines that are available to support clinical hematology laboratory practice.Anti-coagulation assessment with prothrombin time and anti-Xa assays in real-world patients on treatment with rivaroxaban.Assessment of trough rivaroxaban concentrations on markers of coagulation activation in nonvalvular atrial fibrillation population.Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.Atrial fibrillation in kidney transplant recipients: is there a place for the novel drugs?Direct Oral Anticoagulants in Dental Patients Including the Frail Elderly Population.Efficient Synthesis and in Silico Studies of the Benzimidazole Hybrid Scaffold with the Quinolinyloxadiazole Skeleton with Potential α-Glucosidase Inhibitory, Anticoagulant, and Antiplatelet Activities for Type-II Diabetes Mellitus Management and Tr
P2860
Q28067412-CEAC5C1D-0C5D-4C04-88A5-E0E4136861F0Q28072522-740C1301-76C1-4349-BC69-E57631E86EA9Q35154142-00C2A606-6E57-4722-B75B-4B361749BA77Q36331126-7161E077-6C67-4808-808F-904DB51DC641Q36396649-144E9ABD-9C53-4B0C-A10D-394FB6B7D7BAQ36458797-C773E8B8-46CB-4179-BFB2-B59C5D1D71A6Q37293260-22236E61-E0D5-498E-A45E-87511829E1EFQ38269290-D23C8CAC-6B61-4A31-A810-32E3100CC3A4Q38664920-25770EF3-4CCE-448C-9A56-4F011290EC50Q38675822-461E7775-1C33-4E27-A71C-B6939966D534Q38704892-91982277-B280-4EDB-829F-496A7EFC08ECQ38714124-D8B860D3-B6E1-44D8-B706-D1C722D1DD75Q38829586-F220649F-8824-493C-806A-8695A69298F5Q38901666-EE776DEC-9D48-4C33-B99E-15C62DFDBAD2Q40496695-415CCCD2-A53C-4679-8535-4BF16696A379Q42822669-59E707D4-006F-4330-9538-AD3CC198347AQ45856076-930B099D-FCCF-41B5-9365-53B732D1101EQ45857724-7E6F5C40-F789-421E-8627-A88AEB18945DQ45874001-F533F111-0D4B-4123-A25E-61EB622F5C80Q45885174-4DE875E9-3ABC-4AB7-B55A-5CF75484931BQ48028227-58BCF052-2738-46AB-BB54-A099359181B6Q48283692-9D5BF28B-BB37-40D8-9158-AED00D7B0D81Q48285817-DA86E15C-40ED-4368-AC94-23E4D0CA3244Q48316287-2C23D192-FCFD-44AA-837C-AB6B8CF77684Q48350779-C9602168-8C5F-438C-BDB5-73C0A5A06F8DQ48585687-584A7C73-DFAC-4F01-9987-77A702101D2BQ51020546-FBC723D7-3305-4633-809F-C7AB40C8F0BEQ51354532-365B242A-AEBD-45CD-8E01-BA4855EF7FC2Q53086069-8C7CCFAD-2F75-4095-9CED-8E8B967BCA5AQ54720771-0AE60381-A5A3-40EC-88D5-FB7247D9D854Q55050376-7497FBBB-D013-4BFA-B9ED-1296BE91AA50Q58581291-9E35CA30-3E68-4375-B07E-3ABB00659460
P2860
Measurement of non-coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Measurement of non-coumarin an ...... for Standards in Haematology.
@en
Measurement of non-coumarin an ...... for Standards in Haematology.
@nl
type
label
Measurement of non-coumarin an ...... for Standards in Haematology.
@en
Measurement of non-coumarin an ...... for Standards in Haematology.
@nl
prefLabel
Measurement of non-coumarin an ...... for Standards in Haematology.
@en
Measurement of non-coumarin an ...... for Standards in Haematology.
@nl
P2093
P2860
P356
P1476
Measurement of non-coumarin an ...... for Standards in Haematology.
@en
P2093
BCSH committee
Elaine Gray
Ian Mackie
Mike Makris
Steve Kitchen
Trevor Baglin
P2860
P304
P356
10.1111/BJH.12975
P407
P577
2014-06-14T00:00:00Z